Mina Kirkova, MA, MSW, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3009 Jackson Ridge Ct, Phoenix, MD 21131 Phone: 410-988-7247 |
Ms. Sara Kathryn Chappelear, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3346 Paper Mill Rd, Phoenix, MD 21131 Phone: 410-666-4060 Fax: 410-666-4068 |
Mrs. Nancy Lee Sharoff, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Cross Creek Ct, Phoenix, MD 21131 Phone: 410-771-4070 Fax: 410-583-0012 |
Mr. Kenneth Barry Sharoff, LCSWC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Cross Creek Ct, Phoenix, MD 21131 Phone: 410-771-4070 |
Gina Hoag, L.C.S.W.-C. M.S. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15 Fairwood View Ct, Phoenix, MD 21131 Phone: 410-917-2421 |
Ms. Penny L Timmons-lemmerman, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3346 Paper Mill Rd, Phoenix, MD 21131 Phone: 410-938-4668 Fax: 410-938-5131 |
News Archive
Aspirin therapy's ability to reduce the risk of colorectal cancer, an association seen in a large number of studies, appears to depend on the drug's inhibition of the COX-2 enzyme, the action that also underlies aspirin's usefulness for treating pain and inflammation.
The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.
Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, according to a new study co-led by researchers at Johns Hopkins Bloomberg School of Public Health.
UCLA scientists have found the first evidence that a specific form of estrogen can protect the brain from degeneration yet not increase the risk for estrogen-induced cancers of the breast and uterus.
Mutations in a gene that codes for the enzyme BRAF kinase have been associated with increased risk for papillary thyroid cancer. An early-stage clinical trial of the BRAF inhibitor vemurafenib resulted in either a partial response or stable disease in patients with PTC and BRAF mutations.
› Verified 3 days ago